Literature DB >> 25492868

Crystal structures of enterovirus 71 (EV71) recombinant virus particles provide insights into vaccine design.

Ke Lyu1, Guang-Chuan Wang2, Ya-Ling He1, Jian-Feng Han3, Qing Ye3, Cheng-Feng Qin4, Rong Chen5.   

Abstract

Hand-foot-and-mouth disease (HFMD) remains a major health concern in the Asia-Pacific regions, and its major causative agents include human enterovirus 71 (EV71) and coxsackievirus A16. A desirable vaccine against HFMD would be multivalent and able to elicit protective responses against multiple HFMD causative agents. Previously, we have demonstrated that a thermostable recombinant EV71 vaccine candidate can be produced by the insertion of a foreign peptide into the BC loop of VP1 without affecting viral replication. Here we present crystal structures of two different naturally occurring empty particles, one from a clinical C4 strain EV71 and the other from its recombinant virus containing an insertion in the VP1 BC loop. Crystal structure analysis demonstrated that the inserted foreign peptide is well exposed on the particle surface without significant structural changes in the capsid. Importantly, such insertions do not seem to affect the virus uncoating process as illustrated by the conformational similarity between an uncoating intermediate of another recombinant virus and that of EV71. Especially, at least 18 residues from the N terminus of VP1 are transiently externalized. Altogether, our study provides insights into vaccine development against HFMD.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Crystal Structure; Infectious Disease; Vaccine; Vaccine Development; Virus Structure

Mesh:

Substances:

Year:  2014        PMID: 25492868      PMCID: PMC4318995          DOI: 10.1074/jbc.M114.624536

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  36 in total

1.  Crystal structure of a human rhinovirus that displays part of the HIV-1 V3 loop and induces neutralizing antibodies against HIV-1.

Authors:  Jianping Ding; Allen D Smith; Sheila C Geisler; Xuejun Ma; Gail Ferstandig Arnold; Eddy Arnold
Journal:  Structure       Date:  2002-07       Impact factor: 5.006

2.  The modification of poliovirus antigens by heat and ultraviolet light.

Authors:  G L LE BOUVIER
Journal:  Lancet       Date:  1955-11-12       Impact factor: 79.321

3.  UCSF Chimera--a visualization system for exploratory research and analysis.

Authors:  Eric F Pettersen; Thomas D Goddard; Conrad C Huang; Gregory S Couch; Daniel M Greenblatt; Elaine C Meng; Thomas E Ferrin
Journal:  J Comput Chem       Date:  2004-10       Impact factor: 3.376

4.  Identification of neutralizing linear epitopes from the VP1 capsid protein of Enterovirus 71 using synthetic peptides.

Authors:  Damian Guang Wei Foo; Sylvie Alonso; Meng Chee Phoon; N P Ramachandran; Vincent Tak Kwong Chow; Chit Laa Poh
Journal:  Virus Res       Date:  2007-01-12       Impact factor: 3.303

5.  Protein structure prediction on the Web: a case study using the Phyre server.

Authors:  Lawrence A Kelley; Michael J E Sternberg
Journal:  Nat Protoc       Date:  2009       Impact factor: 13.491

6.  Morphogenesis of poliovirus. IV. existence of particles sedimenting at 150S and having the properties of provirion.

Authors:  N Guttman; D Baltimore
Journal:  J Virol       Date:  1977-08       Impact factor: 5.103

7.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

8.  PHENIX: a comprehensive Python-based system for macromolecular structure solution.

Authors:  Paul D Adams; Pavel V Afonine; Gábor Bunkóczi; Vincent B Chen; Ian W Davis; Nathaniel Echols; Jeffrey J Headd; Li-Wei Hung; Gary J Kapral; Ralf W Grosse-Kunstleve; Airlie J McCoy; Nigel W Moriarty; Robert Oeffner; Randy J Read; David C Richardson; Jane S Richardson; Thomas C Terwilliger; Peter H Zwart
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-01-22

9.  Identification of immunodominant VP1 linear epitope of enterovirus 71 (EV71) using synthetic peptides for detecting human anti-EV71 IgG antibodies in Western blots.

Authors:  D G W Foo; R X Ang; S Alonso; V T K Chow; S H Quak; C L Poh
Journal:  Clin Microbiol Infect       Date:  2007-12-08       Impact factor: 8.067

10.  Three-dimensional structure of a mouse-adapted type 2/type 1 poliovirus chimera.

Authors:  T O Yeates; D H Jacobson; A Martin; C Wychowski; M Girard; D J Filman; J M Hogle
Journal:  EMBO J       Date:  1991-09       Impact factor: 11.598

View more
  9 in total

1.  Crystal Structures of Yeast-Produced Enterovirus 71 and Enterovirus 71/Coxsackievirus A16 Chimeric Virus-Like Particles Provide the Structural Basis for Novel Vaccine Design against Hand-Foot-and-Mouth Disease.

Authors:  Ke Lyu; Ya-Ling He; Hao-Yang Li; Rong Chen
Journal:  J Virol       Date:  2015-04-01       Impact factor: 5.103

Review 2.  Is a multivalent hand, foot, and mouth disease vaccine feasible?

Authors:  Michel Klein; Pele Chong
Journal:  Hum Vaccin Immunother       Date:  2015-05-26       Impact factor: 3.452

3.  GITRL as a genetic adjuvant enhances enterovirus 71 VP1 DNA vaccine immunogenicity.

Authors:  Jing Yuan; Xinyi Tang; Kai Yin; Jie Tian; Ke Rui; Jie Ma; Chaoming Mao; Jianguo Chen; Liwei Lu; Huaxi Xu; Shengjun Wang
Journal:  Immunol Res       Date:  2015-05       Impact factor: 2.829

Review 4.  Development of Novel Vaccines against Enterovirus-71.

Authors:  Pinn Tsin Isabel Yee; Chit Laa Poh
Journal:  Viruses       Date:  2015-12-30       Impact factor: 5.048

5.  Characterization of human enterovirus71 virus-like particles used for vaccine antigens.

Authors:  Dandan Zhao; Bo Sun; Shiyang Sun; Bin Fu; Chuntian Liu; Dawei Liu; Yanfei Chu; Youlei Ma; Lu Bai; Yongge Wu; Yan Zhou; Weiheng Su; Ali Hou; Linjun Cai; Fei Xu; Wei Kong; Chunlai Jiang
Journal:  PLoS One       Date:  2017-07-21       Impact factor: 3.240

6.  Enhanced enterovirus 71 virus-like particle yield from a new baculovirus design.

Authors:  Shih-Yeh Lin; Chia-Tsui Yeh; Wan-Hua Li; Cheng-Ping Yu; Wen-Chin Lin; Jyh-Yuan Yang; Hsueh-Ling Wu; Yu-Chen Hu
Journal:  Biotechnol Bioeng       Date:  2015-06-30       Impact factor: 4.530

Review 7.  Antivirals blocking entry of enteroviruses and therapeutic potential.

Authors:  Mohd Ishtiaq Anasir; Faisal Zarif; Chit Laa Poh
Journal:  J Biomed Sci       Date:  2021-01-15       Impact factor: 8.410

8.  Treponema primitia α1-2-fucosyltransferase-catalyzed one-pot multienzyme synthesis of fucosylated oligosaccharide lacto-N-fucopentaose I with antiviral activity against enterovirus 71.

Authors:  Yuanyuan Liu; Aijun Tong; Xiaoxiang Gao; Sinan Yuan; Ruting Zhong; Chao Zhao
Journal:  Food Chem X       Date:  2022-02-26

Review 9.  Immunocompetent and Immunodeficient Mouse Models for Enterovirus 71 Pathogenesis and Therapy.

Authors:  Chiaho Shih; Chun-Che Liao; Ya-Shu Chang; Szu-Yao Wu; Chih-Shin Chang; An-Ting Liou
Journal:  Viruses       Date:  2018-11-28       Impact factor: 5.048

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.